ZEEV BRONFELD - Corporate Board Profile

Protalix BioTherapeutics, Inc.

Filing Date	Source Excerpt
2007-12-31	Zeev Bronfeld. Mr. Bronfeld has served as a director of Protalix Ltd. since 1996 and as our director since December 31, 2006. ... Mr. Bronfeld currently serves as a director of Biocell Ltd., Nasvax Ltd., D. Medical Industries Ltd. and Biomedix Incubator Ltd., all of which are public companies traded on the Tel Aviv Stock Exchange. ... The Nominating Committee, currently comprised of Messrs. Bronfeld, Sheratzky and Toussia-Cohen is responsible for assisting the Board of Directors in selecting nominees for election to the Board of Directors and monitoring the composition of the Board of Directors.
2008-10-03	Zeev Bronfeld. Mr. Bronfeld has served as a director of Protalix Ltd. since 1996 and as our director since December 31, 2006. Mr. Bronfeld brings to us vast experience in management and value building of biotechnology companies. Mr. Bronfeld is an experienced businessman who is involved in a number of biotechnology companies. He is a co-founder of Biocell Ltd., an Israeli publicly traded holding company specializing in biotechnology companies and has served as its chief executive officer since 1986. Mr. Bronfeld currently serves as a director of Biocell Ltd., Nasvax Ltd., D. Medical Industries Ltd., and Biomedix Incubator Ltd., all of which are public companies traded on the Tel Aviv Stock Exchange. Mr. Bronfeld is also a director of each of the following privately-held companies: Meitav Technological Incubator Ltd., Innovetica Ltd., Ecocycle Israel Ltd., Contipi Ltd., Nilimedix Ltd., G-Sense Ltd. and L.N. Innovative Technologies. Mr. Bronfeld holds a B.A. in Economics from the Hebrew University.
2009-09-18	Zeev Bronfeld. Mr. Bronfeld has served as a director of Protalix Ltd. since 1996 and as our director since December 31, 2006. ... The following table sets forth information with respect to compensation of our non-employee directors during fiscal year 2008. ... Zeev Bronfeld total compensation $33,000.
2010-10-04	Zeev Bronfeld. Mr. Bronfeld has served as a director of Protalix Ltd. since 1996 and as our director since December 31, 2006. ... Mr. Bronfeld is also a director of each of the following privately-held companies: ... We believe Mr. Bronfeld's qualifications to serve on our Board of Directors include his years of experience in the management of private and public Israeli companies, including life science companies.
2011-09-19	Zeev Bronfeld 60 Interim Chairman of the Board ... Mr. Bronfeld has served as a director ... Mr. Bronfeld is an experienced businessman ... We believe Mr. Bronfeld's qualifications ... ... The following table sets forth information ... Name Age Position Zeev Bronfeld 60 Interim Chairman of the Board ... The following table sets forth information with respect to compensation ... Zeev Bronfeld 33,000 33,000 ... Fees to our current directors were paid by Protalix Ltd. ... ... Mr. Bronfeld is also a director of each of the following privately-held companies ... ... Our Audit Committee has been appointed by the Board of Directors to serve on the Audit Committee until their respective successors have been duly elected ... ... Our Board of Directors has determined that Messrs. Akirov, Bar Shalev, Bronfeld and Sheratzky, Ms. Harel Gross and Dr. Kornberg are "independent" pursuant to the rules of the NYSE Amex.
2013-09-20	Zeev Bronfeld 62 Interim Chairman of the Board ...The following table sets forth information with respect to compensation of our non-employee directors during fiscal year 2012. The fees to our current directors were paid by Protalix Ltd. ...Zeev Bronfeld 96,500 96,500 ...Mr. Bronfeld is a director and Chief Executive Officer of Biocell.
2014-10-09	Zeev Bronfeld has served as a director of Protalix Ltd. since 1996 and as our director since December 31, 2006. ... Mr. Bronfeld currently serves as a director of Biocell Ltd. and the chairman of the board of directors of D.N.A. Biomedical Solutions Ltd. ... Our Audit Committee operates under a formal charter that governs its duties and conduct. ... Messrs. Bar Shalev and Sheratzky, and Mrs. Harel Buchris have been appointed by the Board of Directors to serve on the Audit Committee until their respective successors have been duly elected. After the 2014 Annual Meeting of Shareholders, we anticipate that Mr. Bronfeld will join the Audit Committee. ... The Compensation Committee is currently comprised of Messrs. Bar Shalev and Sheratzky and Mrs. Harel Buchris. ... After the 2014 Annual Meeting of Shareholders, we anticipate that Mr. Bronfeld will join the Compensation Committee. ... The Nominating Committee, currently comprised of Messrs. Bar Shalev and Sheratzky and Mrs. Harel Buchris, is responsible for assisting our Board of Directors in selecting nominees for election to the Board of Directors and monitoring the composition of the Board of Directors. ... After the 2014 Annual Meeting of Shareholders, we anticipate that Mr. Bronfeld will join the Nominating Committee. ... The following table sets forth information with respect to compensation of our non-employee directors during fiscal year 2013. ... Name Zeev Bronfeld Fees Earned or Paid in Cash ($) 160,000 Total ($) 160,000
2015-10-01	Zeev Bronfeld has served as a director of Protalix Ltd. since 1996 and as our director since December 31, 2006. ... Messrs. Bar Shalev and Bronfeld, and Mrs. Harel Buchris have been appointed by the Board of Directors to serve on the Audit Committee. ... The Compensation Committee is currently comprised of Messrs. Bar Shalev and Bronfeld and Mrs. Harel Buchris. ... The Nominating Committee, currently comprised of Messrs. Bar Shalev and Bronfeld and Mrs. Harel Buchris. ... Compensation of Directors table shows Zeev Bronfeld fees earned or paid in cash $113,000, no option awards, total $113,000.
2016-07-01	Zeev Bronfeld has served as a director since December 31, 2006. ... Messrs. Bar Shalev and Bronfeld, and Mrs. Harel Buchris have been appointed by the Board of Directors to serve on the Audit Committee. ... The Compensation Committee is currently comprised of Messrs. Bar Shalev and Bronfeld and Mrs. Harel Buchris. ... The Nominating Committee, currently comprised of Messrs. Bar Shalev and Bronfeld and Mrs. Harel Buchris. ... Compensation of Directors table: Zeev Bronfeld Fees Earned or Paid in Cash ($) 80,000 Option Award(s) ($) 0 Total ($) 80,000.
2017-03-16	Zeev Bronfeld has served as a director since December 2006. ... Our Audit Committee currently consists of Amos Bar Shalev, Zeev Bronfeld and Yodfat Harel Buchris. ... The Compensation Committee is currently comprised of Messrs. Bar Shalev and Bronfeld and Ms. Harel Buchris. ... The Nominating Committee, currently comprised of Messrs. Bar Shalev and Bronfeld and Ms. Harel Buchris. ... Compensation of Directors table shows Zeev Bronfeld fees earned or paid in cash $80,000, total $80,000.
2017-08-25	The following table sets forth information, as of August 10, 2017, regarding beneficial ownership of our common stock: Name and Address of Beneficial Owner Amount and Nature of Beneficial Ownership Percentage of Class (%) Board of Directors and Executive Officers Zeev Bronfeld
2017-09-01	Board of Directors and Executive Officers Zeev Bronfeld Consists of shares of our common stock held by EBC Holdings Ltd., an investment company wholly-owned by Mr. Bronfeld.
2018-03-06	Zeev Bronfeld. Mr. Bronfeld has served as a director of Protalix Ltd. since 1996 and as our director since December 2006. ... Our Audit Committee has been appointed by the Board of Directors to serve on the Audit Committee until their respective successors have been duly elected. ... The Compensation Committee is currently comprised of Messrs. Bar Shalev and Bronfeld and Ms. Harel Buchris. ... The Nominating Committee, currently comprised of Messrs. Bar Shalev and Bronfeld and Ms. Harel Buchris. ... The following table sets forth information with respect to compensation of our non-employee directors during fiscal year 2017. ... Zeev Bronfeld Fees Earned or Paid in Cash ($) 80,000 Total ($) 80,000.
2018-10-17	Zeev Bronfeld(3)
2019-04-12	Zeev Bronfeld. Mr. Bronfeld has served as a director of Protalix Ltd. since 1996 and as our director since December 2006. ... Under these standards, our Board of Directors has determined that Mr. Bronfeld is considered “independent” pursuant to the rules of the NYSE American. ... Our Board of Directors has an Audit Committee, Compensation Committee and Nominating Committee. The following indicates the members of each committee: ... The Audit Committee is currently comprised of Mr. Bronfeld, ... The Compensation Committee is currently comprised of Mr. Bronfeld, ... The Nominating Committee, currently comprised of ... Zeev Bronfeld, ... The following table sets forth information with respect to compensation of our non-employee directors during fiscal year 2018. ... Zeev Bronfeld Fees Earned or Paid in Cash ($) 80,000 Total ($) 80,000.
2019-10-15	August — Unanimous election of Zeev Bronfeld as the Chairman of the Board
2020-04-15	Zeev Bronfeld. Mr. Bronfeld has served as the Chairman of our Board of Directors since August 2019. ... Director's fees payable to Zeev Bronfeld are paid to a company under his control in accordance with an arrangement between Mr. Bronfeld and such company. ... The following table sets forth information with respect to compensation of our non-employee directors during fiscal year 2019. ... Zeev Bronfeld 80,000
2021-06-04	Zeev Bronfeld. Mr. Bronfeld has served as the Chairman of our Board of Directors since August 2019. ... The Board of Directors approved a new compensation program for our non-employee directors, commencing as of January 1, 2020. ... We granted to the Chairman of the Board an option to purchase 240,000 shares of our common stock, which option vests quarterly in 16 equal increments over a four-year period. As part of the compensation program, the Chairman of the Board of Directors is not entitled to cash compensation. His compensation is limited to equity compensation. ... Fees Earned or Paid in Cash ($): 0, Option Award(s) ($): 340,791, Total ($): 340,791.
2021-09-30	Zeev Bronfeld Consists of 216,247 outstanding shares of our common stock held by EBC Holdings Ltd., an investment company wholly-owned by Mr. Bronfeld
2022-04-29	Zeev Bronfeld. Mr. Bronfeld has served as the Chairman of our Board of Directors since August 2019. He has served as a director of Protalix Ltd., our wholly-owned subsidiary and sole operating unit, since 1996 and as our director since December 2006. Mr. Bronfeld brings to us vast experience in management and value building of biotechnology companies. He is an experienced businessman who is involved in a number of biotechnology companies. He was a co-founder of Bio-cell Ltd., a former Israeli publicly-traded holding company that specialized in biotechnology companies and served as its Chief Executive Officer from 1986 through 2015. Mr. Bronfeld currently serves as a director of The Trendlines Group (SGX:42T) and Electreon Wireless Ltd. (TASE:ELWS) (formerly, Biomedix Incubator Ltd.), both of which are public companies. Mr. Bronfeld is also a director of a number of privately-held companies, most of which are involved in the life sciences industry, such as Contipi Medical Ltd. From August 2010 through April 2021, Mr. Bronfeld served as a director of Entera Bio Ltd. (NASDAQ: ENTX), from November 2009 through February 2021, he served as a director of D.N.A. Biomedical Solutions Ltd. (TASE:DNA) and from January 2008 through January 2017, he served as a director of Macrocure Ltd., a Nasdaq-listed company that merged into Leap Therapeutics, Inc. (NASDAQ:LPTX). Mr. Bronfeld received a B.A. in Economics from the Hebrew University in 1975. We believe Mr. Bronfeld’s qualifications to serve on our Board of Directors include his years of experience in the management of private and public Israeli companies, including life science companies.
2023-05-18	Zeev Bronfeld. Mr. Bronfeld has served as the Chairman of our Board of Directors since August 2019. He has served as a director of Protalix Ltd., our wholly-owned subsidiary and sole operating unit, since 1996 and as our director since December 2006. Mr. Bronfeld brings to us vast experience in management and value building of biotechnology companies. He is an experienced businessman who is involved in a number of biotechnology companies. He was a co-founder of Bio-cell Ltd., a former Israeli publicly-traded holding company that specialized in biotechnology companies and served as its Chief Executive Officer from 1986 through 2015. Mr. Bronfeld currently serves as a director of The Trendlines Group (SGX:42T), a company listed on the Singapore Exchange. Mr. Bronfeld is also a director of a number of privately-held companies, most of which are involved in the life sciences industry, such as Contipi Medical Ltd. From April 2017 through November 2022 Mr. Bronfeld served as a director of Electreon Wireless Ltd. (TASE:ELWS) (formerly, Biomedix Incubator Ltd.), from August 2010 through April 2021, he served as a director of Entera Bio Ltd. (NASDAQ: ENTX), and from November 2009 through February 2021, he served as a director of D.N.A. Biomedical Solutions Ltd. (TASE:DNA) and from January 2008 through January 2017, he served as a director of Macrocure Ltd., a Nasdaq-listed company that merged into Leap Therapeutics, Inc. (NASDAQ:LPTX). Mr. Bronfeld received a B.A. in Economics from the Hebrew University in 1975. We believe Mr. Bronfeld’s qualifications to serve on our Board of Directors include his years of experience in the management of private and public Israeli companies, including life science companies.